News & Events

July 26, 2011	ALPER BIOTECH SIGNS DISTRIBUTION AGREEMENT WITH FISHER SCIENTIFIC ROCKVILLE, MD — Alper Biotech, LLC announced today that the company has signed a distribution agreement with Fisher Scientific, a premier brand of Thermo Fisher Scientific, Inc. Under the terms of the agreement, Fisher Scientific will market Alper Biotech’s immunohistochemistry and R&D kits, which are derived from Alper Biotech’s novel biomarkers and monoclonal antibodies. “We are excited to be entering this relationship with Fisher Scientific, which is a world leader in marketing R&D products,” said Alper Biotech CEO Özge Alper. “This is a significant opportunity for our company as we continue to grow and develop products.” About Thermo Fisher Scientific, Inc. Thermo Fisher Scientific is a global leader in serving science. Fisher Scientific, one of the corporation’s premier brands, provides a complete portfolio of laboratory equipment, chemicals, supplies and services for research, safety, healthcare and science education. For more information, visit www.thermofisher.com.
June 22, 2011	Alper Biotech launches product line of research and development kits using monoclonal antibodies for applications in Western Blot, Indirect-Immunofluourescence and Flow Cytometry analytic techniques.
June 14, 2011	Alper Biotech CEO Özge Alper participates in healthcare roundtable sponsored by JP Morgan.
March 2011	Alper Biotech and Harvard Medical School pursuing collaborative research on filamin A protein specific to breast cancer.

April 17, 2010	Alper Biotech launches its Immunohistochemistry (IHC) Kits, used in cancer for diagnosis, staging, prognosis and directing treatment.
January 15, 2008	Alper Biotech launches its online store with its first product
October 19, 2007	Alper Biotech moves into the the Maryland Technology Development Center (MTDC)
June 30, 2007	Alper Biotech is certified by the State of Maryland as a Qualified Biotechnology Company

November 6, 2006

Alper Biotech, LLC is formed